UCB-Pharma SA - Neupro 6 mg/24h, dispositif transdermique
57417
11
Neupro 6 mg/24h
dispositif transdermique
N04BC09
Rotigotine
05.03.2014
Composition
rotigotinum 13.50 mg, silicone adhesive, povidonum K 90, E 223, E 304, E 307, poly(ethylenis terephthalas), ad praeparationem pro 30 cm², cum liberatione 6 mg/24h.